Association between betatrophin/ANGPTL8 and non-alcoholic fatty liver disease: Animal and human studies

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Lee, Yong Ho ^a   Lee, Sang Guk ^a   Lee, Chan Joo ^b   Kim, Soo Hyun ^a   Song, Young Mi ^a   Yoon, Mi Ra ^a   Jeon, Byung Hun ^a   Lee, Jae Hyuk ^c   Lee, Byung Wan ^a   Kang, Eun Seok ^a   Lee, Hyun Chul ^a   Cha, Bong Soo ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Seonam University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN-LIKE PROTEIN 8, MOUSE; LIPASIN PROTEIN, HUMAN; PALMITIC ACID DERIVATIVE; PEPTIDE HORMONE; TUNICAMYCIN;

ANIMAL; BLOOD; BODY MASS; C57BL MOUSE; CASE CONTROL STUDY; CELL PROLIFERATION; CHEMISTRY; COMORBIDITY; COMPLICATION; DIABETES COMPLICATIONS; ENDOPLASMIC RETICULUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEP-G2 CELL LINE; HUMAN; LIVER; LIVER CELL; MALE; METABOLISM; MOUSE; NONALCOHOLIC FATTY LIVER; OBESITY; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION;

ANGIOPOIETINS; ANIMALS; BODY MASS INDEX; CASE-CONTROL STUDIES; CELL PROLIFERATION; COMORBIDITY; DIABETES COMPLICATIONS; ENDOPLASMIC RETICULUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEP G2 CELLS; HEPATOCYTES; HUMANS; LIVER; MALE; MICE; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PALMITATES; PEPTIDE HORMONES; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; TUNICAMYCIN;

EID: 84963646014     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24013     Document Type: Article

References (42)

1. Loomba, R. and Sanyal, A. J. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 10, 686-690 (2013).
2. Blachier, M. et al. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 58, 593-608 (2013).
3. Targher, G., Day, C. P. and Bonora, E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363, 1341-1350 (2010).
4. Stefan, N., Kantartzis, K. and Haring, H. U. Causes and metabolic consequences of Fatty liver. Endocr Rev 29, 939-960 (2008).
5. Anstee, Q. M., Targher, G. and Day, C. P. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 10, 330-344 (2013).
6. Ekstedt, M. et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44, 865-873 (2006).
7. Soderberg, C. et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 51, 595-602 (2010).
8. Fracanzani, A. L. et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology 48, 792-798 (2008).
9. Zhang, R. and Abou-Samra, A. B. A dual role of lipasin (betatrophin) in lipid metabolism and glucose homeostasis: consensus and controversy. Cardiovasc Diabetol 13, 133 (2014).
10. Wang, Y. et al. Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc Natl Acad Sci USA 110, 16109-16114 (2013).
11. Tang, T. et al. A mouse knockout library for secreted and transmembrane proteins. Nat Biotechnol 28, 749-755 (2010).
12. Zhang, R. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun 424, 786-792 (2012).
13. Ren, G., Kim, J. Y. and Smas, C. M. Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. Am J Physiol Endocrinol Metab 303, E334-351 (2012).
14. Yi, P., Park, J. S. and Melton, D. A. Betatrophin: a hormone that controls pancreatic beta cell proliferation. Cell 153, 747-758 (2013).
15. Fu, Z., Yao, F., Abou-Samra, A. B. and Zhang, R. Lipasin, thermoregulated in brown fat, is a novel but atypical member of the angiopoietin-like protein family. Biochem Biophys Res Commun 430, 1126-1131 (2013).
16. Espes, D., Lau, J. and Carlsson, P. O. Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes. Diabetologia 57, 50-53 (2014).
17. Fu, Z. et al. Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity. Sci Rep 4, 5013 (2014).
18. Espes, D., Martinell, M. and Carlsson, P. O. Increased circulating betatrophin concentrations in patients with type 2 diabetes. Int J Endocrinol 2014, 323407 (2014).
19. Hu, H. et al. Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients. Diabetes Care 37, 2718-2722 (2014).
20. Utzschneider, K. M. and Kahn, S. E. Review: The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 91, 4753-4761 (2006).
21. Imrie, D. and Sadler, K. C. Stress management: How the unfolded protein response impacts fatty liver disease. J Hepatol 57, 1147-1151 (2012).
22. Quagliarini, F. et al. Atypical angiopoietin-like protein that regulates ANGPTL3. Proc Natl Acad Sci USA 109, 19751-19756 (2012).
23. Gusarova, V. et al. ANGPTL8/betatrophin does not control pancreatic beta cell expansion. Cell 159, 691-696 (2014).
24. Tseng, Y. H. et al. Chromosome 19 open reading frame 80 is upregulated by thyroid hormone and modulates autophagy and lipid metabolism. Autophagy 10, 20-31 (2014).
25. Horton, J. D. et al. Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J Clin Invest 101, 2331-2339 (1998).
26. Gao, M. and Liu, D. The liver X receptor agonist T0901317 protects mice from high fat diet-induced obesity and insulin resistance. AAPS J 15, 258-266 (2013).
27. Flamment, M., Hajduch, E., Ferre, P. and Foufelle, F. New insights into ER stress-induced insulin resistance. Trends Endocrinol Metab 23, 381-390 (2012).
28. Yoon, H. J. and Cha, B. S. Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease. World J Hepatol 6, 800-811 (2014).
29. Fu, Z., Abou-Samra, A. B. and Zhang, R. An explanation for recent discrepancies in levels of human circulating betatrophin. Diabetologia 57, 2232-2234 (2014).
30. Chen, X. et al. Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance. J Clin Endocrinol Metab 100, E96-E100 (2015).
31. Ebert, T. et al. Circulating Angiopoietin-like Protein 8 Is Independently Associated With Fasting Plasma Glucose and Type 2 Diabetes Mellitus. J Clin Endocrinol Metab 99, E2510-2517 (2014).
32. Gomez-Ambrosi, J. et al. Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes. J Clin Endocrinol Metab 99, E2004-2009 (2014).
33. Fenzl, A. et al. Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulinresistant individuals. Diabetologia 57, 1204-1208 (2014).
34. Haukeland, J. W. et al. Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies. Eur J Endocrinol 166, 503-510 (2012).
35. Choi, H. Y. et al. Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic Fatty liver disease. Diabetes Metab J 37, 63-71 (2013).
36. Saadeh, S. et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123, 745-750 (2002).
37. Limanond, P. et al. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 230, 276-280 (2004).
38. American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care 37 Suppl 1, S14-80 (2014).
39. Lee, Y. H. et al. A simple screening score for diabetes for the Korean population: development, validation, and comparison with other scores. Diabetes Care 35, 1723-1730 (2012).
40. Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419 (1985).
41. Baron, R. M. and Kenny, D. A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51, 1173-1182 (1986).
42. R Core Team R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/. (2013).